SCA
NEOS

Stonebridge Capital Advisors’s Neos Therapeutics, Inc NEOS Stock Holding History

Stonebridge Capital Advisors’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,000
Closed -$5K – 788
2020
Q2 		$5K Sell
7,000
-3,000
-30% -$2.38K ﹤0.01% 579
2020
Q1 		$8K Hold
10,000
– – ﹤0.01% 515
2019
Q4 		$15K Hold
10,000
– – ﹤0.01% 499
2019
Q3 		$15K Buy
+10,000
New +$16.2K ﹤0.01% 504

Other funds holding NEOS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stonebridge Capital Advisors's NEOS Position: Q3 2020 in Review

Stonebridge Capital Advisors sold out of Neos Therapeutics, Inc (NEOS) in Q3 2020, closing a stake of 7,000 shares — an estimated $5K sold.

Stonebridge Capital Advisors first reported a position in NEOS in Q3 2019 and held it in 4 quarters. The position peaked at $15K in Q4 2019. 41 funds tracked by Wall St. Rank hold NEOS as of Q3 2020.

  • Stonebridge Capital Advisors reported no remaining Neos Therapeutics, Inc position as of Q3 2020 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 7,000 Neos Therapeutics, Inc shares in Q3 2020, an estimated $5K.
  • Stonebridge Capital Advisors first reported a position in Neos Therapeutics, Inc in Q3 2019 and held it in 4 quarters.
  • Stonebridge Capital Advisors's Neos Therapeutics, Inc position peaked at $15K in Q4 2019.
  • 41 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q3 2020.

Based on Stonebridge Capital Advisors's 13F filing for Q3 2020, filed 18 Nov 2020.